Head & Neck Cancer Drugs Market to 2027 - Global Analysis and Forecasts by Product (PD Inhibitors, Microtubule Inhibitors, EGFR Inhibitors); Application (Surgery, Radiation therapy, Chemotherapy, Immunotherapy)
Report Code: TIPRE00007725 No. of Pages: 151 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
Head & neck cancer is especially common in regions having high alcohol and tobacco intake, and the most common type is squamous cell carcinoma. About 9 out of 10 head and neck cancers begin inside squamous cells. Chemotherapy drugs commonly used to treat head and neck cancers are cisplatin, carboplatin, and docetaxel. The EGFR-targeted drug, in combination with chemotherapy or radiation therapy for head and neck cancers, such as laryngeal or hypopharyngeal cancer, is a targeted therapy drug for head & neck cancer.
MARKET DYNAMICS
The head & neck cancer drugs market is anticipated to grow in the market by the rise in demand for combination therapy for the management of head & neck cancer, and growth in the number of R&D activities to develop ideal therapeutic. Furthermore, technological advancements in screening procedures for cancer and a strong presence of pipeline drugs such as Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib, Afatinib, Bevacizumab, and others are expected to drive the market growth. Also, the rise in the number of risk factors such as growth in the number of cigarette smoking, alcohol & tobacco consumption is further anticipated to boost the market.
MARKET SCOPE
The "Head & Neck Cancer Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in head & neck cancer drugs market with detailed market segmentation by product, application and geography. The head & neck cancer drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in head & neck cancer drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The head & neck cancer drugs market is segmented on the basis of product and by application. Based on product the market is segmented as PD inhibitors, microtubule inhibitors and EGFR inhibitors. On the basis of application the market is categorized as surgery, radiation therapy, chemotherapy and immunotherapy.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in head & neck cancer drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The head & neck cancer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting head & neck cancer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the head & neck cancer drugs market in these regions.
The report covers key developments in the in head & neck cancer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in head & neck cancer drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for in head & neck cancer drugs market in the global market. Below mentioned is the list of few companies engaged in the in head & neck cancer drugs market.
The report also includes the profiles of key in head & neck cancer drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Head & neck cancer is especially common in regions having high alcohol and tobacco intake, and the most common type is squamous cell carcinoma. About 9 out of 10 head and neck cancers begin inside squamous cells. Chemotherapy drugs commonly used to treat head and neck cancers are cisplatin, carboplatin, and docetaxel. The EGFR-targeted drug, in combination with chemotherapy or radiation therapy for head and neck cancers, such as laryngeal or hypopharyngeal cancer, is a targeted therapy drug for head & neck cancer.
MARKET DYNAMICS
The head & neck cancer drugs market is anticipated to grow in the market by the rise in demand for combination therapy for the management of head & neck cancer, and growth in the number of R&D activities to develop ideal therapeutic. Furthermore, technological advancements in screening procedures for cancer and a strong presence of pipeline drugs such as Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib, Afatinib, Bevacizumab, and others are expected to drive the market growth. Also, the rise in the number of risk factors such as growth in the number of cigarette smoking, alcohol & tobacco consumption is further anticipated to boost the market.
MARKET SCOPE
The "Head & Neck Cancer Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in head & neck cancer drugs market with detailed market segmentation by product, application and geography. The head & neck cancer drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in head & neck cancer drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The head & neck cancer drugs market is segmented on the basis of product and by application. Based on product the market is segmented as PD inhibitors, microtubule inhibitors and EGFR inhibitors. On the basis of application the market is categorized as surgery, radiation therapy, chemotherapy and immunotherapy.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in head & neck cancer drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The head & neck cancer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting head & neck cancer drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the head & neck cancer drugs market in these regions.
The report covers key developments in the in head & neck cancer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in head & neck cancer drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for in head & neck cancer drugs market in the global market. Below mentioned is the list of few companies engaged in the in head & neck cancer drugs market.
The report also includes the profiles of key in head & neck cancer drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AstraZeneca Plc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
- Fresenius Medical Care AG & Co. KGaA
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Limited
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Head And Neck Cancer Drug Market - By Product
1.3.2 Head And Neck Cancer Drug Market - By Application
1.3.3 Head And Neck Cancer Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEAD AND NECK CANCER DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEAD AND NECK CANCER DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEAD AND NECK CANCER DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. HEAD AND NECK CANCER DRUG - GLOBAL MARKET OVERVIEW
6.2. HEAD AND NECK CANCER DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HEAD AND NECK CANCER DRUG MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PD INHIBITORS
7.3.1. Overview
7.3.2. PD Inhibitors Market Forecast and Analysis
7.4. MICROTUBULE INHIBITORS
7.4.1. Overview
7.4.2. Microtubule Inhibitors Market Forecast and Analysis
7.5. EGFR INHIBITORS
7.5.1. Overview
7.5.2. EGFR Inhibitors Market Forecast and Analysis
8. HEAD AND NECK CANCER DRUG MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. SURGERY
8.3.1. Overview
8.3.2. Surgery Market Forecast and Analysis
8.4. RADIATION THERAPY
8.4.1. Overview
8.4.2. Radiation therapy Market Forecast and Analysis
8.5. CHEMOTHERAPY
8.5.1. Overview
8.5.2. Chemotherapy Market Forecast and Analysis
8.6. IMMUNOTHERAPY
8.6.1. Overview
8.6.2. Immunotherapy Market Forecast and Analysis
9. HEAD AND NECK CANCER DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Head And Neck Cancer Drug Market Overview
9.1.2 North America Head And Neck Cancer Drug Market Forecasts and Analysis
9.1.3 North America Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.1.4 North America Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.1.5 North America Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Head And Neck Cancer Drug Market
9.1.5.1.1 United States Head And Neck Cancer Drug Market by Product
9.1.5.1.2 United States Head And Neck Cancer Drug Market by Application
9.1.5.2 Canada Head And Neck Cancer Drug Market
9.1.5.2.1 Canada Head And Neck Cancer Drug Market by Product
9.1.5.2.2 Canada Head And Neck Cancer Drug Market by Application
9.1.5.3 Mexico Head And Neck Cancer Drug Market
9.1.5.3.1 Mexico Head And Neck Cancer Drug Market by Product
9.1.5.3.2 Mexico Head And Neck Cancer Drug Market by Application
9.2. EUROPE
9.2.1 Europe Head And Neck Cancer Drug Market Overview
9.2.2 Europe Head And Neck Cancer Drug Market Forecasts and Analysis
9.2.3 Europe Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.2.4 Europe Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.2.5 Europe Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Head And Neck Cancer Drug Market
9.2.5.1.1 Germany Head And Neck Cancer Drug Market by Product
9.2.5.1.2 Germany Head And Neck Cancer Drug Market by Application
9.2.5.2 France Head And Neck Cancer Drug Market
9.2.5.2.1 France Head And Neck Cancer Drug Market by Product
9.2.5.2.2 France Head And Neck Cancer Drug Market by Application
9.2.5.3 Italy Head And Neck Cancer Drug Market
9.2.5.3.1 Italy Head And Neck Cancer Drug Market by Product
9.2.5.3.2 Italy Head And Neck Cancer Drug Market by Application
9.2.5.4 Spain Head And Neck Cancer Drug Market
9.2.5.4.1 Spain Head And Neck Cancer Drug Market by Product
9.2.5.4.2 Spain Head And Neck Cancer Drug Market by Application
9.2.5.5 United Kingdom Head And Neck Cancer Drug Market
9.2.5.5.1 United Kingdom Head And Neck Cancer Drug Market by Product
9.2.5.5.2 United Kingdom Head And Neck Cancer Drug Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Head And Neck Cancer Drug Market Overview
9.3.2 Asia-Pacific Head And Neck Cancer Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Head And Neck Cancer Drug Market
9.3.5.1.1 Australia Head And Neck Cancer Drug Market by Product
9.3.5.1.2 Australia Head And Neck Cancer Drug Market by Application
9.3.5.2 China Head And Neck Cancer Drug Market
9.3.5.2.1 China Head And Neck Cancer Drug Market by Product
9.3.5.2.2 China Head And Neck Cancer Drug Market by Application
9.3.5.3 India Head And Neck Cancer Drug Market
9.3.5.3.1 India Head And Neck Cancer Drug Market by Product
9.3.5.3.2 India Head And Neck Cancer Drug Market by Application
9.3.5.4 Japan Head And Neck Cancer Drug Market
9.3.5.4.1 Japan Head And Neck Cancer Drug Market by Product
9.3.5.4.2 Japan Head And Neck Cancer Drug Market by Application
9.3.5.5 South Korea Head And Neck Cancer Drug Market
9.3.5.5.1 South Korea Head And Neck Cancer Drug Market by Product
9.3.5.5.2 South Korea Head And Neck Cancer Drug Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Head And Neck Cancer Drug Market Overview
9.4.2 Middle East and Africa Head And Neck Cancer Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Head And Neck Cancer Drug Market
9.4.5.1.1 South Africa Head And Neck Cancer Drug Market by Product
9.4.5.1.2 South Africa Head And Neck Cancer Drug Market by Application
9.4.5.2 Saudi Arabia Head And Neck Cancer Drug Market
9.4.5.2.1 Saudi Arabia Head And Neck Cancer Drug Market by Product
9.4.5.2.2 Saudi Arabia Head And Neck Cancer Drug Market by Application
9.4.5.3 U.A.E Head And Neck Cancer Drug Market
9.4.5.3.1 U.A.E Head And Neck Cancer Drug Market by Product
9.4.5.3.2 U.A.E Head And Neck Cancer Drug Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Head And Neck Cancer Drug Market Overview
9.5.2 South and Central America Head And Neck Cancer Drug Market Forecasts and Analysis
9.5.3 South and Central America Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.5.4 South and Central America Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.5.5 South and Central America Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Head And Neck Cancer Drug Market
9.5.5.1.1 Brazil Head And Neck Cancer Drug Market by Product
9.5.5.1.2 Brazil Head And Neck Cancer Drug Market by Application
9.5.5.2 Argentina Head And Neck Cancer Drug Market
9.5.5.2.1 Argentina Head And Neck Cancer Drug Market by Product
9.5.5.2.2 Argentina Head And Neck Cancer Drug Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. HEAD AND NECK CANCER DRUG MARKET, KEY COMPANY PROFILES
11.1. ASTRAZENECA PLC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BRISTOL-MYERS SQUIBB COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELI LILLY AND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. F. HOFFMANN-LA ROCHE LTD. (GENENTECH, INC.,)
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. FRESENIUS MEDICAL CARE AG AND CO. KGAA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK AND CO., INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANOFI
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUN PHARMACEUTICAL INDUSTRIES LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Head And Neck Cancer Drug Market - By Product
1.3.2 Head And Neck Cancer Drug Market - By Application
1.3.3 Head And Neck Cancer Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEAD AND NECK CANCER DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEAD AND NECK CANCER DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEAD AND NECK CANCER DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. HEAD AND NECK CANCER DRUG - GLOBAL MARKET OVERVIEW
6.2. HEAD AND NECK CANCER DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HEAD AND NECK CANCER DRUG MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PD INHIBITORS
7.3.1. Overview
7.3.2. PD Inhibitors Market Forecast and Analysis
7.4. MICROTUBULE INHIBITORS
7.4.1. Overview
7.4.2. Microtubule Inhibitors Market Forecast and Analysis
7.5. EGFR INHIBITORS
7.5.1. Overview
7.5.2. EGFR Inhibitors Market Forecast and Analysis
8. HEAD AND NECK CANCER DRUG MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. SURGERY
8.3.1. Overview
8.3.2. Surgery Market Forecast and Analysis
8.4. RADIATION THERAPY
8.4.1. Overview
8.4.2. Radiation therapy Market Forecast and Analysis
8.5. CHEMOTHERAPY
8.5.1. Overview
8.5.2. Chemotherapy Market Forecast and Analysis
8.6. IMMUNOTHERAPY
8.6.1. Overview
8.6.2. Immunotherapy Market Forecast and Analysis
9. HEAD AND NECK CANCER DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Head And Neck Cancer Drug Market Overview
9.1.2 North America Head And Neck Cancer Drug Market Forecasts and Analysis
9.1.3 North America Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.1.4 North America Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.1.5 North America Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Head And Neck Cancer Drug Market
9.1.5.1.1 United States Head And Neck Cancer Drug Market by Product
9.1.5.1.2 United States Head And Neck Cancer Drug Market by Application
9.1.5.2 Canada Head And Neck Cancer Drug Market
9.1.5.2.1 Canada Head And Neck Cancer Drug Market by Product
9.1.5.2.2 Canada Head And Neck Cancer Drug Market by Application
9.1.5.3 Mexico Head And Neck Cancer Drug Market
9.1.5.3.1 Mexico Head And Neck Cancer Drug Market by Product
9.1.5.3.2 Mexico Head And Neck Cancer Drug Market by Application
9.2. EUROPE
9.2.1 Europe Head And Neck Cancer Drug Market Overview
9.2.2 Europe Head And Neck Cancer Drug Market Forecasts and Analysis
9.2.3 Europe Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.2.4 Europe Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.2.5 Europe Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Head And Neck Cancer Drug Market
9.2.5.1.1 Germany Head And Neck Cancer Drug Market by Product
9.2.5.1.2 Germany Head And Neck Cancer Drug Market by Application
9.2.5.2 France Head And Neck Cancer Drug Market
9.2.5.2.1 France Head And Neck Cancer Drug Market by Product
9.2.5.2.2 France Head And Neck Cancer Drug Market by Application
9.2.5.3 Italy Head And Neck Cancer Drug Market
9.2.5.3.1 Italy Head And Neck Cancer Drug Market by Product
9.2.5.3.2 Italy Head And Neck Cancer Drug Market by Application
9.2.5.4 Spain Head And Neck Cancer Drug Market
9.2.5.4.1 Spain Head And Neck Cancer Drug Market by Product
9.2.5.4.2 Spain Head And Neck Cancer Drug Market by Application
9.2.5.5 United Kingdom Head And Neck Cancer Drug Market
9.2.5.5.1 United Kingdom Head And Neck Cancer Drug Market by Product
9.2.5.5.2 United Kingdom Head And Neck Cancer Drug Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Head And Neck Cancer Drug Market Overview
9.3.2 Asia-Pacific Head And Neck Cancer Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Head And Neck Cancer Drug Market
9.3.5.1.1 Australia Head And Neck Cancer Drug Market by Product
9.3.5.1.2 Australia Head And Neck Cancer Drug Market by Application
9.3.5.2 China Head And Neck Cancer Drug Market
9.3.5.2.1 China Head And Neck Cancer Drug Market by Product
9.3.5.2.2 China Head And Neck Cancer Drug Market by Application
9.3.5.3 India Head And Neck Cancer Drug Market
9.3.5.3.1 India Head And Neck Cancer Drug Market by Product
9.3.5.3.2 India Head And Neck Cancer Drug Market by Application
9.3.5.4 Japan Head And Neck Cancer Drug Market
9.3.5.4.1 Japan Head And Neck Cancer Drug Market by Product
9.3.5.4.2 Japan Head And Neck Cancer Drug Market by Application
9.3.5.5 South Korea Head And Neck Cancer Drug Market
9.3.5.5.1 South Korea Head And Neck Cancer Drug Market by Product
9.3.5.5.2 South Korea Head And Neck Cancer Drug Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Head And Neck Cancer Drug Market Overview
9.4.2 Middle East and Africa Head And Neck Cancer Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Head And Neck Cancer Drug Market
9.4.5.1.1 South Africa Head And Neck Cancer Drug Market by Product
9.4.5.1.2 South Africa Head And Neck Cancer Drug Market by Application
9.4.5.2 Saudi Arabia Head And Neck Cancer Drug Market
9.4.5.2.1 Saudi Arabia Head And Neck Cancer Drug Market by Product
9.4.5.2.2 Saudi Arabia Head And Neck Cancer Drug Market by Application
9.4.5.3 U.A.E Head And Neck Cancer Drug Market
9.4.5.3.1 U.A.E Head And Neck Cancer Drug Market by Product
9.4.5.3.2 U.A.E Head And Neck Cancer Drug Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Head And Neck Cancer Drug Market Overview
9.5.2 South and Central America Head And Neck Cancer Drug Market Forecasts and Analysis
9.5.3 South and Central America Head And Neck Cancer Drug Market Forecasts and Analysis - By Product
9.5.4 South and Central America Head And Neck Cancer Drug Market Forecasts and Analysis - By Application
9.5.5 South and Central America Head And Neck Cancer Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Head And Neck Cancer Drug Market
9.5.5.1.1 Brazil Head And Neck Cancer Drug Market by Product
9.5.5.1.2 Brazil Head And Neck Cancer Drug Market by Application
9.5.5.2 Argentina Head And Neck Cancer Drug Market
9.5.5.2.1 Argentina Head And Neck Cancer Drug Market by Product
9.5.5.2.2 Argentina Head And Neck Cancer Drug Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. HEAD AND NECK CANCER DRUG MARKET, KEY COMPANY PROFILES
11.1. ASTRAZENECA PLC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BRISTOL-MYERS SQUIBB COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELI LILLY AND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. F. HOFFMANN-LA ROCHE LTD. (GENENTECH, INC.,)
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. FRESENIUS MEDICAL CARE AG AND CO. KGAA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK AND CO., INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANOFI
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUN PHARMACEUTICAL INDUSTRIES LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. AstraZeneca Plc.
2. Bristol-Myers Squibb Company
3. Eli Lilly and Company
4. F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
5. Fresenius Medical Care AG & Co. KGaA
6. Merck & Co., Inc.
7. Pfizer Inc.
8. Sanofi
9. Sun Pharmaceutical Industries Ltd.
10. Teva Pharmaceutical Industries Limited
1. AstraZeneca Plc.
2. Bristol-Myers Squibb Company
3. Eli Lilly and Company
4. F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
5. Fresenius Medical Care AG & Co. KGaA
6. Merck & Co., Inc.
7. Pfizer Inc.
8. Sanofi
9. Sun Pharmaceutical Industries Ltd.
10. Teva Pharmaceutical Industries Limited